Detalhe da pesquisa
1.
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
Eur Heart J
; 44(2): 129-138, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331326
2.
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia.
N Engl J Med
; 382(16): 1520-1530, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197277
3.
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
N Engl J Med
; 382(16): 1507-1519, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187462
4.
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial.
Eur Heart J
; 43(48): 5047-5057, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331315
5.
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.
Hepatology
; 71(4): 1198-1212, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30805949
6.
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
PLoS Med
; 17(9): e1003222, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956407
7.
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.
J Hepatol
; 70(4): 735-744, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529590
8.
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
J Hepatol
; 70(3): 483-493, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30414864
9.
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 391(10126): 1174-1185, 2018 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519502
10.
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.
Pharmacol Res
; 136: 140-150, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30219580
11.
Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia.
Pain Med
; 17(4): 728-36, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26814307
12.
Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11ß-HSD1 Inhibitor Xanamem® for Mild Alzheimer's Disease.
J Alzheimers Dis
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38848180
13.
Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials.
Alzheimers Dement
; 9(1 Suppl): S45-55, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22658286
14.
Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension study.
Brain Commun
; 5(1): fcad026, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861013
15.
Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trial.
Brain Commun
; 4(6): fcac300, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519155
16.
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Parkinsonism Relat Disord
; 96: 65-73, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227940
17.
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
JAMA Neurol
; 79(10): 1005-1014, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036925
18.
Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials.
Alzheimers Dement
; 7(6): 602-610.e2, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21745761
19.
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.
Clin Ophthalmol
; 15: 4035-4048, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675472
20.
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.
Clin Ophthalmol
; 15: 2743-2751, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211263